BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29478368)

  • 1. Identification of the Differential Expression Profiles of Serum and Tissue Proteins During Rat Hepatocarcinogenesis.
    Sheng X; Huang T; Qin J; Yang L; Sa ZQ; Li Q
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618756785. PubMed ID: 29478368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
    Aravalli RN; Talbot NC; Steer CJ
    World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
    Yamashita H; Surapureddi S; Kovi RC; Bhusari S; Ton TV; Li JL; Shockley KR; Peddada SD; Gerrish KE; Rider CV; Hoenerhoff MJ; Sills RC; Pandiri AR
    Arch Toxicol; 2020 Jul; 94(7):2523-2541. PubMed ID: 32306082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
    Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonally Induced Hepatocellular Carcinoma in Diabetic Wild Type and Carbohydrate Responsive Element Binding Protein Knockout Mice.
    Nuernberger V; Mortoga S; Metzendorf C; Burkert C; Ehricke K; Knuth E; Zimmer J; Singer S; Nath N; Karim M; Yasser M; Calvisi DF; Dombrowski F; Ribback S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal expression of
    Zheng WJ; Yao M; Fang M; Wang L; Dong ZZ; Yao DF
    World J Gastroenterol; 2018 Aug; 24(32):3650-3662. PubMed ID: 30166860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic mining in the dysplastic liver of WHV/c-myc mice--insights and indicators for early hepatocarcinogenesis.
    Liu Y; Li C; Xing Z; Yuan X; Wu Y; Xu M; Tu K; Li Q; Wu C; Zhao M; Zeng R
    FEBS J; 2010 Oct; 277(19):4039-53. PubMed ID: 20807235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.
    Yao M; Yao DF; Bian YZ; Zhang CG; Qiu LW; Wu W; Sai WL; Yang JL; Zhang HJ
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):289-94. PubMed ID: 21669573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic and Proteomic Analysis of Steatohepatitic Hepatocellular Carcinoma Reveals Novel Distinct Biologic Features.
    Van Treeck BJ; Mounajjed T; Moreira RK; Orujov M; Allende DS; Bellizzi AM; Lagana SM; Davila JI; Jessen E; Graham RP
    Am J Clin Pathol; 2021 Jan; 155(1):87-96. PubMed ID: 32885245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.
    Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF
    Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic and Proteomic Investigation of HSP90A as a Potential Biomarker for HCC.
    Zhou Y; Deng X; Zang N; Li H; Li G; Li C; He M
    Med Sci Monit; 2015 Dec; 21():4039-49. PubMed ID: 26704341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.
    Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q
    J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation.
    Yan XD; Yao M; Wang L; Zhang HJ; Yan MJ; Gu X; Shi Y; Chen J; Dong ZZ; Yao DF
    World J Gastroenterol; 2013 Sep; 19(36):6084-92. PubMed ID: 24106410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
    Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
    J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
    Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
    Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
    Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of oval cells and c-myc mRNA expression in mouse hepatocarcinogenesis.
    Fang CH; Zhang GQ; Zhu XY; Gong JQ
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):433-9. PubMed ID: 15313684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.